Trials / Recruiting
RecruitingNCT06158971
Feasibility Study of the Microwave Ablation System for Lung Tissue Ablation
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- phenoMapper, LLC · Industry
- Sex
- All
- Age
- 45 Years – 77 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of safety and technical feasibility of the phenoWave MW Ablation System for microwave ablation of lesions in the lung.
Detailed description
This study is a prospective, single-arm, single-center, study to evaluate the safety and technical feasibility of using the phenoWave MW Ablation System to deliver microwave energy for ablation of lesions in the lung.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Flexible Bronchoscopic Microwave Ablation | The phenoWave flexible microwave ablation system will be used to perform soft tissue ablation in the lungs under image guidance. |
Timeline
- Start date
- 2024-03-12
- Primary completion
- 2025-01-31
- Completion
- 2025-01-31
- First posted
- 2023-12-06
- Last updated
- 2024-04-04
Locations
1 site across 1 country: Australia
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06158971. Inclusion in this directory is not an endorsement.